Overview

Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
To collect the efficacy and safety information of Eplerenone on patients with hypertension related to their appropriate use in daily practice.
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Eplerenone